Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (8)

1

The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment

enthalten in: Blood advances | 2023

von Eickhardt-Dalbøge, C. | Ingham, A. | Andersen, L. | +13

2

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

enthalten in: Blood advances | 2022

von Knudsen, T. | Skov, V. | Stevenson, K. | +29

3

Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms

enthalten in: European journal of haematology | 2017

von Hansen, I. | Sørensen, A. | Hasselbalch, H.

4

Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms

enthalten in: Leukemia research | 2014

von Christensen, A. | Møller, J. | Hasselbalch, H.

5

Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

enthalten in: Blood | 2011

von Riley, C. | Jensen, M. | Brimnes, M. | +4

6

Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

enthalten in: Hematology (Amsterdam, Netherlands) | 2009

von Larsen, T. | Pallisgaard, N. | de Stricker, K. | +2

7

Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis

enthalten in: American journal of hematology | 2003

von Hasselbalch, H. | Bjerrum, O. | Jensen, B. | +5

8

Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan

enthalten in: American journal of hematology | 2003

von Nielsen, I. | Hasselbalch, H.

1
[1]